24 related articles for article (PubMed ID: 15043540)
1. Expression of VEGF-C in rat cornea after alkali injury.
Jiang D; Hu Y; Ling S
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(5):483-5. PubMed ID: 15641699
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analyses of corneal tissue subjected to alkali exposure.
Parikh T; Eisner N; Venugopalan P; Yang Q; Lam BL; Bhattacharya SK
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1819-31. PubMed ID: 20861482
[TBL] [Abstract][Full Text] [Related]
3. Double-masked, sham and placebo-controlled trial of corneal cross-linking and topical difluprednate in the treatment of bacterial keratitis: Steroids and Cross-linking for Ulcer Treatment Trial (SCUT II) study protocol.
Radhakrishnan N; Prajna VN; Prajna LS; Venugopal A; Narayana S; Rajaraman R; Amescua G; Porco TC; Lietman TM; Rose-Nussbaumer J
BMJ Open Ophthalmol; 2021; 6(1):e000811. PubMed ID: 34901464
[TBL] [Abstract][Full Text] [Related]
4. Controlled delivery of pirfenidone through vitamin E-loaded contact lens ameliorates corneal inflammation.
Dixon P; Ghosh T; Mondal K; Konar A; Chauhan A; Hazra S
Drug Deliv Transl Res; 2018 Oct; 8(5):1114-1126. PubMed ID: 29858820
[TBL] [Abstract][Full Text] [Related]
5. Update on the Management of Infectious Keratitis.
Austin A; Lietman T; Rose-Nussbaumer J
Ophthalmology; 2017 Nov; 124(11):1678-1689. PubMed ID: 28942073
[TBL] [Abstract][Full Text] [Related]
6. Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation.
Soiberman U; Kambhampati SP; Wu T; Mishra MK; Oh Y; Sharma R; Wang J; Al Towerki AE; Yiu S; Stark WJ; Kannan RM
Biomaterials; 2017 May; 125():38-53. PubMed ID: 28226245
[TBL] [Abstract][Full Text] [Related]
7. Role of steroids in the treatment of bacterial keratitis.
Palioura S; Henry CR; Amescua G; Alfonso EC
Clin Ophthalmol; 2016; 10():179-86. PubMed ID: 26869751
[TBL] [Abstract][Full Text] [Related]
8. Alkali burn treated with 2% rebamipide ophthalmic suspension: a case report.
Sasaki H; Kokubun T
Case Rep Ophthalmol; 2014; 5(3):380-5. PubMed ID: 25762927
[TBL] [Abstract][Full Text] [Related]
9. Effects of awakening and the use of topical dexamethasone and levofloxacin on the cytokine levels in tears following corneal transplantation.
Fodor M; Petrovski G; Pásztor D; Gogolák P; Rajnavölgyi É; Berta A
J Immunol Res; 2014; 2014():570685. PubMed ID: 25371908
[TBL] [Abstract][Full Text] [Related]
10. Topical Corticosteroids in the Management of Bacterial Keratitis.
Tuli SS
Curr Ophthalmol Rep; 2013 Dec; 1(4):. PubMed ID: 24404432
[TBL] [Abstract][Full Text] [Related]
11. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury.
Yamada J; Dana MR; Sotozono C; Kinoshita S
Exp Eye Res; 2003 Feb; 76(2):161-7. PubMed ID: 12565803
[TBL] [Abstract][Full Text] [Related]
12. Treatment of alkali-injured cornea by cyclosporine A-loaded electrospun nanofibers - An alternative mode of therapy.
Cejkova J; Cejka C; Trosan P; Zajicova A; Sykova E; Holan V
Exp Eye Res; 2016 Jun; 147():128-137. PubMed ID: 27181227
[TBL] [Abstract][Full Text] [Related]
13. Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A.
Benelli U; Ross JR; Nardi M; Klintworth GK
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):274-82. PubMed ID: 9040459
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of early systemic betamethasone or cyclosporin A after corneal alkali injury via inflammatory cytokine reduction.
Den S; Sotozono C; Kinoshita S; Ikeda T
Acta Ophthalmol Scand; 2004 Apr; 82(2):195-9. PubMed ID: 15043540
[TBL] [Abstract][Full Text] [Related]
15. Effect of metalloproteinase inhibitor on corneal cytokine expression after alkali injury.
Sotozono C; He J; Tei M; Honma Y; Kinoshita S
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2430-4. PubMed ID: 10476814
[TBL] [Abstract][Full Text] [Related]
16. Alkali burn to the eye: protection using TNF-α inhibition.
Cade F; Paschalis EI; Regatieri CV; Vavvas DG; Dana R; Dohlman CH
Cornea; 2014 Apr; 33(4):382-9. PubMed ID: 24488127
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
